ClinConnect ClinConnect Logo
Search / Trial NCT06611462

STRONG for Surgery & Strong for Life - Intensive Prehabilitation for Risk Reduction in Ventral Hernia Repair

Launched by BISPEBJERG HOSPITAL · Sep 20, 2024

Trial Information

Current as of April 02, 2025

Recruiting

Keywords

Ventral Hernia Surgery Risk Reduction Postoperative Complications Prehabilitation Smoking Alcohol Drinking Obesity Malnutrition Physical Inactivity

ClinConnect Summary

The STRONG for Surgery & Strong for Life trial is studying how a program that focuses on improving risky lifestyle habits can help patients prepare for surgery to repair a ventral hernia. The program aims to address five key areas: smoking, nutrition, alcohol intake, physical activity, and overall lifestyle choices. Researchers believe that by helping patients make healthier choices before surgery, they can reduce complications after the surgery, potentially cutting complications in half within the first 30 days.

To participate in this trial, you need to be at least 18 years old and scheduled for ventral hernia repair surgery, with a hernia size smaller than 8 cm. You should also have enough time to undergo at least four weeks of the program and be screened for at least one of the risky lifestyle factors. The trial is open to all genders, and participants can expect to receive personalized support to help them improve their health before their surgery. It's an opportunity to not only prepare for surgery but also to build healthier habits for the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Participants ≥18 years scheduled for ventral hernia repair (defect smaller than 8cm)
  • Enough time for at least 4 weeks of prehabilitation
  • Screened positive for at least 1 risky SNAP factor
  • Signed informed consent
  • Exclusion Criteria:
  • Ventral hernia repairs with defect larger than 8 cm
  • Pregnancy/breastfeeding
  • Allergy/other contradiction to pharmaceutical and/or nutritional support
  • Contradiction to exercise
  • Previous complicated alcohol withdrawal symptoms (delirium or seizures)
  • Not able to participate in intervention due to psychiatric ilness

Trial Officials

Hanne Tønnesen, Professor MD

Principal Investigator

WHOCC, The Parker Institute, Bispebjerg-Frederiksberg Hospital, RegH, Copenhagen

About Bispebjerg Hospital

Bispebjerg Hospital is a leading healthcare institution located in Copenhagen, Denmark, renowned for its commitment to innovative medical research and clinical excellence. As a key sponsor of clinical trials, the hospital focuses on advancing healthcare by exploring novel therapies and treatment protocols across various medical disciplines. With a multidisciplinary team of experienced researchers and clinicians, Bispebjerg Hospital aims to enhance patient outcomes through rigorous scientific inquiry and evidence-based practices, while fostering collaboration with academic institutions and industry partners to drive progress in the medical field.

Locations

Herlev, , Denmark

Køge, , Denmark

Holbæk, , Denmark

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported